How bacteria beat immune systems

The evolution of more severe infections is not necessarily driven by bacteria multiplying faster, new research shows. Humans and animals can develop resistance to harmful bacteria (pathogens) over time or with antibiotics or vaccines, and it is usually assumed that pathogens respond by multiplying faster.

The new study shows pathogen virulence and replication rates can evolve separately. The researchers  believe that, once resistance spreads in host species, virulence may be driven by other means such as by manipulating host immune systems.

The research examined the spread of bacteria called Mycoplasma gallisepticum among house finches -- a rare example of a well-studied host-bacteria evolution where humans have not intervened with antibiotics or vaccines.

The study shows that pathogens can evolve to become more virulent without increasing their rate of replication. The researchers hypothesise that the increase in virulence that observed in this study was driven by an improved ability of the pathogen to manipulate the host immune system in order to generate the symptoms necessary for its transmission.

For example, if trying to kill the pathogen inevitably leads to more virulent infections, it might be worth trying to slow down pathogen evolution by combining treatments that both eliminate the pathogen and prevent it manipulating host immune systems.

Some populations of house finches have been exposed to Mycoplasma gallisepticum for more than 20 years, while others have not -- and have therefore not developed resistance.

In the study, carried out in Arizona and supported by Arizona State University and Auburn University, 57 finches from previously unexposed populations were exposed to the pathogen.

The findings show virulence has increased consistently over more than 150,000 bacterial generations since outbreak (1994 to 2015).

By contrast, while replication rates increased from outbreak to the initial spread of resistance (1994 to 2004), no further increases have occurred subsequently (2007 to 2015).

See:

Luc Tardy, Mathieu Giraudeau, Geoffrey E. Hill, Kevin J. McGraw, Camille Bonneaud. Contrasting evolution of virulence and replication rate in an emerging bacterial pathogen. Proceedings of the National Academy of Sciences, 2019; 201901556 DOI: 10.1073/pnas.1901556116

Posted by Dr. Tim Sandle, Pharmaceutical Microbiology